Keymed Biosciences Inc.
HKEX:2162.HK
43.55 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 851.029 | 604.07 | 1,520.619 | 199.409 | 432.608 |
| Short Term Investments
| 1,868.157 | 2,571.256 | 2,003.96 | 154.673 | 66.341 |
| Cash and Short Term Investments
| 2,719.186 | 3,175.326 | 3,524.579 | 354.082 | 498.949 |
| Net Receivables
| 27.091 | 0.48 | 10.55 | -10.394 | -66.341 |
| Inventory
| 56.354 | 44.495 | 16.393 | 6.846 | 3.306 |
| Other Current Assets
| 311.274 | 315.024 | 77.795 | 25.9 | 82.43 |
| Total Current Assets
| 2,939.531 | 3,309.974 | 3,581.949 | 380.917 | 518.405 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 910.94 | 596.465 | 306.481 | 126.147 | 128.94 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 5.234 | 1.496 | 1.104 | 0.109 | 0.038 |
| Goodwill and Intangible Assets
| 5.234 | 1.496 | 1.104 | 0.109 | 0.038 |
| Long Term Investments
| 21.63 | -2,550.685 | -1,983.679 | 0 | 0 |
| Tax Assets
| -21.327 | 2,550.685 | 0 | 0 | 0 |
| Other Non-Current Assets
| 26.914 | 24.381 | 2,028.6 | 22.772 | 11.195 |
| Total Non-Current Assets
| 943.391 | 622.342 | 352.506 | 149.028 | 140.173 |
| Total Assets
| 3,882.922 | 3,932.316 | 3,934.455 | 529.945 | 658.578 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 29.488 | 14.913 | 2.784 | 3.418 | 3.478 |
| Short Term Debt
| 65.252 | 72.241 | 12.277 | 46.551 | 52.177 |
| Tax Payables
| 1.82 | 1.026 | 0.935 | 0.161 | 0.107 |
| Deferred Revenue
| -19.427 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 238.867 | 292.545 | 97.014 | 30.271 | 15.935 |
| Total Current Liabilities
| 314.18 | 379.699 | 112.075 | 80.24 | 71.59 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 353.457 | 49.728 | 26.985 | 20.314 | 24.271 |
| Deferred Revenue Non-Current
| 228.194 | 163.671 | 8.719 | 6.786 | 1.587 |
| Deferred Tax Liabilities Non-Current
| 0.278 | 28.8 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | -28.8 | 141.294 | 1,517.408 | 837.085 |
| Total Non-Current Liabilities
| 581.929 | 213.399 | 176.998 | 1,544.508 | 862.943 |
| Total Liabilities
| 896.109 | 593.098 | 289.073 | 1,624.748 | 934.533 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.169 | 0.17 | 0.171 | 0.045 | 0.045 |
| Retained Earnings
| -5,649.364 | -5,290.007 | 3,650.799 | -1,094.583 | -276 |
| Accumulated Other Comprehensive Income/Loss
| 2,986.142 | 144.972 | 116.823 | 0 | 0 |
| Other Total Stockholders Equity
| 5,649.364 | 8,485.153 | -116.823 | 0 | 0 |
| Total Shareholders Equity
| 2,986.311 | 3,340.288 | 3,650.97 | -1,094.538 | -275.955 |
| Total Equity
| 2,986.813 | 3,339.218 | 3,645.382 | -1,094.803 | -275.955 |
| Total Liabilities & Shareholders Equity
| 3,882.922 | 3,932.316 | 3,934.455 | 529.945 | 658.578 |